Findings
========

Background
----------

Chromium compounds are widely used in industry as chromium compound manufacturing, electroplating, leather tanning, welding, corrosion inhibitors, and alloying metal, etc. The respiratory tract is the major way of occupational exposure to chromium besides oral and dermal exposure. Trivalent chromium(Cr(III)) compound, an essential micronutrient, has been considered to be lower toxicity \[[@B1]\]. Previous studies \[[@B2]-[@B6]\] have revealed that hexavalent chromium (Cr(VI)) compounds could induce DNA damage. Exposure to Cr(VI) significantly increases the risk of respiratory tract cancer \[[@B7],[@B8]\], thus Cr(VI) has been classified as a human carcinogen (group 1) by the International Agency for the Research on Cancer (IARC) \[[@B9]\].

Although the mechanisms involved in Cr(VI) induced damage remains to be fully elucidated, generation of reactive oxygen species (ROS) was likely the key step in the intracellular reduction of Cr(VI) by cellular reductant such as reduced glutathione (GSH) and ascorbic acid. The excessive production of ROS may lead to oxidative stress, DNA damage \[[@B4],[@B10]\]. Common forms of DNA damage include DNA strand breaks, chromium-DNA adducts, cross-links and oxidative DNA damage \[[@B2]-[@B4],[@B11]\]. However, induced DNA damage could be repaired through individual repair system to maintain the genomic stability. The common mechanisms of DNA repair include base excision repair (BER), nucleotide excision repair (NER), mismatch repair, etc. Therefore, the residue DNA damage, which associates with the risk of lung cancer and other diseases, is dependent on capability of DNA repair. High inter- individual variation of DNA damage had been found in the previous studies on chromium exposure \[[@B2],[@B12]\]. Therefore, the individual DNA repair capacity might modulate the DNA damage and associate with the risk of involved diseases under chromium exposure. DNA repair gene polymorphisms, which may alter the efficiency of DNA repair, contribute to genetic susceptibility of DNA damage. Hence, we hypothesize that the genetic variation of 9 major DNA repair genes could modulated the Cr(VI)- induced damage and might serve as the genetic biomarkers of susceptibility.

To examine this hypothesis, we recruited 157 chromium-exposed electroplating workers and 93 control subjects. DNA damage in peripheral lymphocytes was evaluated with alkaline comet assay. Nine polymorphisms of DNA repair genes XRCC1 Arg399Gln, XRCC1Arg194Trp, ERCC1 C8092A, ERCC5 His1104Asp, ERCC6 Gly399Asp, GSTP1Ile105Val, OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln were determined. The associations between these polymorphism markers and the Cr (VI)- induced DNA damage were analyzed.

Materials and Methods
=====================

Study subjects
--------------

157 electroplating workers were recruited from 20 electroplating factories in Hangzhou, China from 2009--2010. Control subjects (n = 93) were recruited from the workers without exposure to chromium compounds and other known physical or chemical genotoxic agents. Subjects with abnormal liver or kidney function and suffering from other chronic diseases such as cancers, diabetes, heart diseases were excluded in the study. All the subjects were interviewed for information of age, smoking habits, alcohol consumption, medical history and years of chromium exposure. Short- term sampling of air was conducted according to Specifications of Air Sampling for Hazardous Substances Monitoring in the Workplace in China (GBZ159-2004). Airborne chromium concentration was measured by graphite furnace atomic absorption spectrophotometer (M6 Thermo, USA). About 4 ml of peripheral vein blood sample was collected from each subject and drawn into two vacuum tubes containing 3.6 mg of EDTA. 2 ml of blood was stored at 4°C for determining chromium levels and the comet assay, and the other was stored at −80°C for DNA isolation and genotyping. The study protocol was approved by the Institutional Review Board of Hangzhou Center for Disease Control and Prevention. Written informed consent was obtained from each subject.

DNA damage determination
------------------------

The alkaline comet assay was employed to detect the DNA damage in peripheral lymphocytes. The alkaline comet assay was performed as previously described with some modifications \[[@B13]\]. Peripheral blood (10 μl) was mixed with 75 ul of 0.75% low-melting- point agarose and transferred to a microscope slide pre-coated with a layer of 0.75% normal-melting-point agarose. The slides were immersed in the lysis buffer (2.5 mol/L NaCl, 100 mmol/L EDTA, 10 mmol/L Tris, freshly added 1% Triton X-100 and 10% DMSO, pH 10) for 1 h at 4°C to remove proteins. The slides were then placed in a horizontal electrophoresis tank containing electrophoresis buffer (300 mmol/L NaOH, 1 mmol/L EDTA, pH 13) for 20 min to allow DNA unwinding. The electrophoresis was carried out in the same buffer for 20 min. After electrophoresis, the slides were neutralized in the neutralization buffer (0.4 mol/L Tris, pH 7.5), and then stained with 50 μL ethidium bromide solution (20 μg/mL). All the steps were conducted under yellow light to prevent additional DNA damage. One hundred nuclei were selected randomly from each sample. The observation was made at 400× magnification using a fluorescence microscope (DMI 4000) equipped with a 530-nm excitation filter and a computer-based image analysis program CASP. The medians of Olive tail moment, tail length and tail DNA% were used for assessing DNA damage. Olive tail moment is defined as the product of the tail length and the fraction of total DNA in the tail and calculated as \[(tail mean - head mean) × (tail DNA%/100)\] \[[@B13]\].

Genotyping
----------

DNA was extracted from peripheral lymphocytes using genomic DNA extraction kits (Tiangen blood genomic DNA extraction kits, Tiangen, China). The genotypes of XRCC1 Arg194Trp and Arg399Gln were determined with PCR-RFLP. The primers of amplification were as follows: XRCC1 Arg194Trp:F: 5′-GCC CCG TCC CAG GTA-3′,R: 5′-AGC CCC AAG ACC CTT TCA CT-3′;XRCC1 Arg399Gln:F: 5′-TTG TGC TTT CTC TGT GTC CA-3′,R: 5′-TCC TCC AGC CTT TTC TGA TA-3′. PCR for XRCC1 Arg194Trp and XRCC1 Arg399Gln were performed under the following conditions: 95°C for 5 min, followed by 30 cycles of 94°C for 40s, 56°C (Arg399Gln) or 61 °C (Arg194Trp) for 30 s and 72°C for 30 s and a final elongation step at 72°C for 10 min. Then the PCR products were digested at 37°C for 12 h with restricted endonucleases MspI (NEB, USA) (Arg399Gln) or PvuII (Arg194Trp). The 10 μL of digested PCR products were electrophoresed on a 2% agarose gel. For Arg399Gln, one band of 615 bp represents gln/gln, two bands (375 bp and 240 bp) represent arg/arg, and three bands (615 bp, 375 bp and 240 bp) represent arg/gln. For Arg194Trp, one band of 491 bp represents arg/arg, two bands (197 bp and 294 bp) represent trp/trp, and three bands (197 bp, 294 bp and 491 bp) represent arg/gln. The genotypes of ERCC1 C8092A, ERCC5 His1104Asp, ERCC6 Gly399Asp, GSTP1Ile105Val, OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln were detected using TaqMan probe- based real time PCR (7900, ABI, USA). The primer and probe sequences were obtained from the National Cancer Institute's SNP500Cancer database. Negative controls and previously genotyped samples were included in each plate to ensure the accuracy of the genotyping.

Statistical analysis
--------------------

Because distribution of DNA damage data (olive tail moment, tail length and tail DNA%) do not follow normal distribution, the median and P~25~-P~75~ was used to summarize the central location and variation of data, and compared among genotype groups using non-parametric test (Kruskal-Wallis test). Chi square test was used to compare frequency data. A goodness-of-fit Chi square test was used to evaluate for the Hardy-Weinberg equilibrium. Multivariate linear (the DNA damage data was square root-transformed) and logistic models were used to adjust the potential confounding variables including age, gender, smoking status, drinking and occupational exposure time of chromium. A two-sided *P* value of less than 0.05 was considered statistically significant. All statistical calculations were performed by using SPSS 16.0.

Results
=======

Characteristics of the study population
---------------------------------------

The mean age (± standard deviation) of exposed subjects was 39.7 ± 8.3 years while 38.8 ± 9.6 years for control group (*P \>* 0.05). There were no significant differences in gender, smoking status, alcohol consumption between the two groups (all *P* values *\>* 0.05). The median time of chromium exposure was 5.3 years (range: 0.5 to 23 years).

The median of short-term exposure concentration of chromium in the air at the 20 electroplating workplaces was 0.060 mg/m^3^ (range from 0.016 to 0.531 mg/m^3^), which was higher than the permissible concentration short term exposure limit (PC-STEL) of chromium in China (0.05 mg/m^3^), and 52% factories had chromium level above the standard of PC-STEL.

The chromium concentration in erythrocytes and DNA damage in exposed and control subjects
-----------------------------------------------------------------------------------------

Chromium concentrations in erythrocytes and DNA damage in exposed and control groups were shown in Table  [1](#T1){ref-type="table"}. The exposed subjects had the median (P~25~-P~75~) of chromium concentration in erythrocytes of 4.41 μg/l (2.50, 5.29), which was about two times higher than that in control subjects (1.54 μg/l (0.61--2.98), *P* \< 0.001). The medians of Olive tail moment, tail length and tail DNA% in exposed group were 1.13(0.47--1.45), 11.77 (6.42--14.84) and 3.69 (2.50--5.29), respectively, and were significantly higher than those in control subjects (0.12 (0.04--0.22), 3.26 (3.00--4.00) and 0.59 (0.19--1.11) (*P* \< 0.001).

###### 

The chromium concentration in erythrocytes (μg/l) and DNA damage in exposed and control subjects

                                                  **Exposed subjects n = 149**   **Control subjects n = 77**   ***P value***^a^
  ----------------------------------------------- ------------------------------ ----------------------------- ------------------
  chromium concentration in erythrocytes (μg/l)   4.41 (2.50--5.29)              1.54 (0.61--2.98)             \<0.001
  Olive tail moment                               1.13 (0.47--1.45)              0.12 (0.04--0.22)             \<0.001
  Tail Length                                     11.77 (6.42--14.84)            3.26 (3.00--4.00)             \<0.001
  Tail DNA%                                       3.69 (2.50--5.29)              0.59 (0.19--1.11)             \<0.001

1\. Data were presented as median (P~25~-P~75~).

2\. *P* values were calculated with rank sum test between the exposed and control subjects.

3\. Owing to missing detect in DNA damage and genotype, the numbers of subjects in Table  [2](#T2){ref-type="table"} were less 157 in exposed group and 93 in control group.

Genotypes of the polymorphism of XRCC1 Arg399Gln and the DNA damage induced by Cr (VI) exposure
-----------------------------------------------------------------------------------------------

The allele frequencies for XRCC1 399Gln, XRCC1 194Trp, OGG1 326Cys, ERCC1 8092A, ERCC5 1104Asp, ERCC6 399Asp, XPD 751Gln, XPC 939Gln, GSTP1105Val were 0.24, 0.24, 0.54, 0.57, 0.49, 0.46, 0.08, 0.38, 0.16, respectively. Genotype distributions of all the polymorphisms studied were all consistent with Hardy-Weinberg equilibrium (*P* \> 0.05). The medians and P~25~-P~75~ of Olive tail moment, tail length and tail DNA% in the subjects with different genotypes were shown in Table  [2](#T2){ref-type="table"}.

###### 

DNA damage in the exposed subjects with different genotypes of polymorphisms

  **SNP**            **genotype**   **n**   **Olive tail moment**   **Tail length**   **Tail DNA%**                              
  ------------------ -------------- ------- ----------------------- ----------------- --------------- ------------- ------------ ------------
  XRCC1 Arg399Gln    GG             70      0.93                    0.58--1.79        9.74            6.89--18.14   3.25         1.94--5.58
  GA                 42             0.73    0.46--1.35              8.19              5.93--13.79     2.50          1.77--4.36   
  AA                 8              0.50    0.43--0.93              6.64              5.00--9.92      1.91          1.43--3.03   
                     *P*^\*^                0.048                   0.050             0.039                                      
                     AA + GA        50      0.66                    0.44--1.31        8.00            5.69--13.74   2.32         1.66--4.33
                     *P*^∮^                 0.043                   0.067             0.046                                      
  XRCC1 Arg194Trp    CC             66      0.75                    0.47--1.45        8.55            6.30--14.22   2.82         1.66--4.85
  CT                 49             0.91    0.48--1.49              9.69              6.97--16.25     3.22          1.83--4.75   
  TT                 5              0.66    0.37--1.82              7.67              5.11--16.94     2.39          1.29--5.84   
                     *P*^\*^                0.973                   0.964             0.992                                      
  OGG1 Ser326Cys     CC             18      1.09                    0.41--1.84        11.72           4.92--18.87   3.63         1.55--5.80
  CG                 56             0.86    0.47--1.46              9.18              6.50--15.53     3.07          1.73--4.86   
  GG                 41             0.78    0.56--1.19              8.93              6.87--12.07     2.69          2.02--4.15   
                     *P*^\*^                0.462                   0.335             0.377                                      
  ERCC1 C8092A       CC             20      0.84                    0.45--1.38        9.79            6.56--15.53   3.20         1.77--4.72
  CA                 47             0.71    0.47--1.43              8.10              5.81--14.10     2.45          1.61--4.53   
  AA                 49             0.92    0.62--1.60              9.66              7.21--17.29     3.22          2.06--5.50   
                     *P*^\*^                0.543                   0.690             0.595                                      
  ERCC5 His1104Asp   GG             25      0.92                    0.62--1.60        9.66            7.21--17.29   3.22         2.06--5.50
  GC                 61             0.84    0.54--1.50              9.66              6.79--15.88     2.84          1.99--4.99   
  CC                 30             0.83    0.50--1.38              9.21              7.01--15.05     3.04          1.81--4.59   
                     *P*^\*^                0.886                   0.931             0.920                                      
  ERCC6 Gly399Asp    CC             32      0.83                    0.49--1.14        8.90            6.82--11.70   3.03         1.87--3.97
  CT                 54             0.75    0.48--1.73              8.26              6.42--16.12     2.75          1.85--5.51   
  TT                 31             1.03    0.48--1.57              10.70             5.72--18.10     3.22          1.68--5.19   
                     *P*^\*^                0.143                   0.152             0.203                                      
  XPD Lys751Gln      AA             94      0.82                    0.48--1.45        9.50            6.42--14.84   2.94         1.81--4.80
  AC                 20             0.81    0.48--1.81              8.79              7.00--16.74     2.88          1.88--5.81   
  CC                 0                                                                                                           
                     *P*^\*^                0.771                   0.742             0.900                                      
  XPC Lys939Gln      GG             45      0.89                    0.56--1.52        9.66            6.97--15.96   2.96         2.02--5.14
  GT                 53             0.83    0.47--1.40              8.87              6.63--14.07     2.75          1.39--6.13   
  TT                 18             0.81    0.39--2.10              9.13              5.68--23.00     2.92          1.73--4.57   
                     *P*^\*^                0.564                   0.379             0.705                                      
  GSTP1 Ile105Val    AA             80      0.83                    0.52--1.58        9.21            6.75--15.65   2.94         1.85--5.30
  AG                 30             0.70    0.38--1.41              8.03              5.71--15.29     2.41          1.62--4.53   
  GG                 6              1.02    0.71--1.84              11.89             8.83--18.95     3.74          2.46--5.83   
                     *P*^\*^                0.169                   0.514             0.463                                      

\* The DNA damage data was square root-transformed and multivariable linear model was used after adjusting confounding factors of gender, age, smoking status, drinking and exposure time of chromium.

Comparing the subjects with GG genotype with AA + GA.

∫ Owing to missing detect in DNA damage and genotype, the numbers of subjects in Table  [2](#T2){ref-type="table"} were less 157 in exposed group.

The median of Olive tail moment (P~25~--P~75~) was 0.93(0.58--1.79) for individuals carrying GG genotype of XRCC1 Arg399Gln (G/A), 0.73 (0.46--1.35) for GA heterozygote and 0.50 (0.43--0.93) for AA genotype, respectively. After adjusting the confounding factors of gender, smoking status, drinking and occupational exposure time of chromium, significant difference in Olive tail moment was found among the subjects with different genotypes (*P* = 0.048). The median of Olive tail moment of the subjects carrying A allele (the genotypes of AA and GA) was 0.66 (0.44--1.31), which was significantly lower than that for those with GG genotype (*P* = 0.043).

Similar results were observed for tail length and tail DNA% in different groups. After adjustment of the potential confounding factors, significant differences were found in tail length (*P* = 0.050) and tail DNA% (*P* = 0.039) among different genotypes. The medians of tail length were 9.74 (6.89--18.14) for individuals carrying GG genotype in XRCC1 Arg399Gln (G/A), 8.19 (5.93--13.79) for GA heterozygote and 6.64 (5.00--9.92) for AA genotype, respectively. The medians of tail DNA% were 3.25 (1.94--5.58) for individuals carrying GG genotype of XRCC1 Arg399Gln (G/A), 2.50 (1.77--4.36) for GA heterozygote and 1.91 (1.43--3.03) for AA genotype, respectively. The median of tail DNA% of the subjects with carrying A allele (the genotypes of AA and GA) was 2.32 (1.66--4.33), which was significantly lower than that for those with GG genotype (*P* = 0.046). A borderline statistical difference was found in tail length when compared the subjects carrying A allele with GG genotype (*P* = 0.067).

No statistical association in Olive tail moment, tail length and tail DNA% was found among different genotypes of XRCC1 Arg194Trp, ERCC1 C8092A, ERCC5 His1104Asp, ERCC6 Gly399Asp, GSTP1 Ile105Val, OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln (all the *P* value \>0.05).

With the 75th percentile of Olive tail moment (1.44) as a cut-off point, the subjects were divided into two groups: high DNA damage (\>1.44) and low DNA damage (≦1.44). 31.4% (22/70) of the subjects carrying GG genotype of XRCC1 Arg399Gln (G/A) had higher DNA damage (\>1.44 of olive tail moment) while only 16.0% (8/50) in the subjects carrying A allele. Dose- response relationship was found between the number of A allele and DNA damage (*P*~trend\ adjusted~ = 0.031). Comparing with the subjects with genotypes of GG, the subject carrying A allele was significantly associated with the reduced risk of DNA damage with the odds ratio of 0.388 (95% CI: 0.152--0.992, *P* = 0.048) after adjusting the potential confounders of gender, smoking status, drinking and exposure time of chromium (Figure  [1](#F1){ref-type="fig"}).

![**The percentage of high DNA damage in different genotypes of XRCC1 399.** DNA damage was quantitatively assessed with Olive tail moment by alkaline comet assay. High DNA damage was defined as great than the value (1.44) of percentile 75 of Olive tail moment.](1756-0500-5-263-1){#F1}

Discussion
==========

In the present study, we found the chromium concentration in erythrocytes was found to be significantly higher in electroplating workers (4.41 μg/l) than that in control subjects. The finding indicated there was hexavalent chromium exposure in electroplating workplace. Occupational chromium exposure in electroplating induced DNA damage. We also found that the polymorphisms of XRCC1 Arg399Gln was associated with Cr(VI)- induced DNA damage. Our findings supported the hypothesis that the genetic variation of major DNA repair genes could modulate the Cr (VI)- induced damage. The DNA repair capacity may associate with the risk of chromium exposure induced disease such as lung cancer and XRCC1 Arg399Gln could be served as a genetic biomarker of susceptibility for chromium exposure.

Cr (VI) compound can actively enter into the cells through the isoelectric and isostructural anion channels \[[@B5]\], phagocytosis \[[@B14]\], et al. Once inside the cell and in the presence of cellular reductants, such as ascorbate and thiols, Cr (VI) compounds can be reduced through short-lived Cr intermediates (Cr (V) and Cr (IV)) to the stable trivalent state Cr (III) \[[@B15]\]. During these reactive processes, reactive oxygen species (ROS) such as hydroxyl radicals, single oxygen, superoxide and hydrogen peroxide, were generated. The resulting excessive production of ROS may lead to oxidative damage, DNA adducts and crosslinks \[[@B16],[@B17]\]. Iarmarcovai et al. \[[@B18]\]. found the binucleated micro-nucleated cell rate in chromium-exposed welding worker was significantly higher than in control subjects. In the previous study \[[@B2]\], we found the Cr (VI) exposed electroplating workers had higher concentrations of 8-OHdG (an indicator of oxidative DNA damage), olive tail moment, tail length and tail DNA% which were evaluated by comet assay. These findings were in agreement of the other previous studies \[[@B3],[@B19]\]. Therefore, Cr (VI) is a genotoxic agent and associated the risk of lung cancer and other occupational diseases \[[@B15]\].

The DNA repair mechanisms are responsible for repairing the xenobiotic induced DNA damage and maintaining the genomic stability. DNA repair system is involved in the repair of Cr (VI)- induced DNA lesion such as Oxidative damage and single strand break, which are the main forms of DNA damage. Base excision repair (BER) pathway is mainly responsible for repair these DNA lesions. X-ray repair cross-complementing group 1(XRCC1) is a key component in repairing both direct SSB and indirect SSB generated indirectly during base excision repair \[[@B20]\]. It serves as a scaffold connecting many of the other proteins involved in SSB repair. XRCC1 is recruited to SSBs by poly(ADP-ribose)polymerase (PARP1) and then interacts with a number of important proteins involved in SSB such as proliferating cell nuclear antigen (PCNA), DNA polymerase beta (Polb), and polynucleotide kinase (PNK) \[[@B20],[@B21]\]. XRCC1 was essential to reduce the formation of lead chromate induced chromatid lesions \[[@B22]\]. XRCC1 protein is involved in the repair of Cr(VI)-induced SSB \[[@B23]\] and in protection from lead chromate--induced chromosome instability \[[@B22]\].

Genetic polymorphisms of key proteins might be involved in inter-individual variations of DNA repair processes and influence the extent of genotoxic damage. XRCC1 Arg399Gln, a functional genetic variation, may alter the capacity of XRCC1 to interact with several acting enzymes and associated with the efficiency of BER repair \[[@B24],[@B25]\]. Many previous studies \[[@B26]-[@B28]\] revealed XRCC1 Arg399Gln was associated with the common cancers such as lung, bladder, esophageal cancers, etc. and modulated the cancer risk for common environmental exposure. In chromium-exposed electroplating workers, we found the polymorphism of XRCC1 Arg399Gln was associated the Olive tail moment, tail length and tail DNA%. The subject carrying A allele reduced the risk of high DNA damage. In the previous studies, XRCC1 Arg399Gln was also found to be associated with chromosome aberrations \[[@B29]\] and micronuclei \[[@B18],[@B30]\] in the chromium exposed welding worker. This polymorphism was also found to modulate the risk of DNA damage induced other occupational exposure to DNA damage agents such as vinyl chloride \[[@B31]\], asbestos \[[@B32]\] and 1,3-butadiene \[[@B33]\].

However, we didn't find significant association between XRCC1 Arg194Trp and the Cr (VI)-induced DNA damage. This finding was inconsistent with the previous studies \[[@B31],[@B33]\]. We also failed to find any associations of the polymorphisms of ERCC1 C8092A, ERCC5 His1104Asp, ERCC6 Gly399Asp, GSTP1 Ile105Val, OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln with the DNA lesions. One of the possible reasons might be the specific effect of the DNA repair proteins responding to Cr (VI)-induced DNA damage. The other might be small sample size and relative low statistical power of test in this study. Only 122 chromium exposed electroplating workers were studied and false negative results might exist. Therefore, further study is required with large sample size and more statistical power to screen new genetic biomarkers of Cr (VI)-induced DNA damage.

In conclusion, we found that the genetic variation of XRCC1 Arg399Gln was associated with the Cr (VI)-induced DNA damage. XRCC1 Arg399Gln may be served as a genetic marker of susceptibility and high risk individual identification for chromium exposed workers. With this genetic biomarker, the susceptible population could be screened and prevent from chromium exposure.
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